Related references
Note: Only part of the references are listed.Stability-indicating capillary electrophoresis method for the simultaneous determination of metformin hydrochloride, saxagliptin hydrochloride, and dapagliflozin in pharmaceutical tablets
Hadir M. Maher et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2019)
Simultaneous spectrophotometric determination of compounds having relatively disparate absorbance and concentration ranges; application to antidiabetic formulation of linagliptin and metformin
Ola M. Abdalla et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2018)
A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index
J. Plotka-Wasylka
TALANTA (2018)
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
K. Ogurtsova et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs loose-dose combination of oral anti-diabetes drugs
Tasneem Lokhandwala et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Combination Therapy When Metformin Is Not an Option for Type 2 Diabetes
Jennifer D. Goldman-Levine
ANNALS OF PHARMACOTHERAPY (2015)
Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals
Frank Lavernia et al.
POSTGRADUATE MEDICINE (2015)
UPLC simultaneous determination of empagliflozin, linagliptin and metformin
Bassam M. Ayoub
RSC ADVANCES (2015)
Analytical Eco-Scale for assessing the greenness of analytical procedures
Agnieszka Galuszka et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2012)
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
Thomas Karagiannis et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Dipeptidyl Peptidase-4 Inhibitors Administered in Combination With Metformin Result in an Additive Increase in the Plasma Concentration of Active GLP-1
E. M. Migoya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care
G. Schernthaner
DIABETIC MEDICINE (2010)
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial
M. Jadzinsky et al.
DIABETES OBESITY & METABOLISM (2009)
Share Paper
